Login Register Cart 0
Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Effect of Initial Vancomycin Dose and Creatinine Clearance on the Attainment of Target Trough Concentration in Children

Author(s): Ha Manh Tuan, Nguyen Tuan Anh*, Kim Tran Quan, Nguyen Van Thang and Vu Quang Huy

Volume 18, Issue 4, 2022

Published on: 12 April, 2022

Page: [318 - 325] Pages: 8

DOI: 10.2174/1573396318666220307115307

Price: $65

Abstract

Background: Vancomycin is a glycopeptide antibiotic that is used to treat serious grampositive infections. However, therapeutic drug monitoring for vancomycin is not performed routinely in Vietnam in clinical practices. Monitoring of serum vancomycin concentration or trough levels is necessary to ensure the efficacy and safety of vancomycin therapy.

Objective: This study aims to determine the impact of initial vancomycin dose and creatinine clearance on target trough attainment in hospitalized Vietnamese children.

Methods: A prospective study with patients who received vancomycin for at least three days was conducted. Subsequently, demographic data, clinical diagnosis, vancomycin dosage, and serum creatinine levels were recorded. The vancomycin trough level was collected and creatinine clearance and adjusted vancomycin doses were calculated.

Results: A total of 40 eligible patients were enrolled. Patients’ mean age, body weight, and height were 1.4 years old, 9.8 kg, and 75.5 cm, respectively. The mean vancomycin dose was 55.83 ± 19.34 mg/kg/day. The mean creatinine clearance was 80.18 ± 29.14 ml/min. The median trough level was 11.09 (7.84 - 16.46) μg/ml. There was no significant difference in the mean initial and the adjusted vancomycin doses (p = 0.062). However, there were statistically significant differences of initial (p = 0.004) or adjusted doses (p = 0.016) between groups of creatinine clearance. The trough vancomycin concentration was not statistically significant (p = 0.406) between these groups.

Conclusion: Target trough vancomycin level may be associated with creatinine clearance but did not proportionally correspond to the vancomycin dose. Therefore, monitoring vancomycin trough levels is necessary to achieve the target trough and to ensure vancomycin efficacy and safety in treating severely infected Vietnamese children.

Keywords: Creatinine clearance, initial dose, trough concentration, vancomycin, Vietnamese children, vancomycin efficacy.

« Previous Next »
Graphical Abstract

[1]
Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42(6): 2398-402.
[http://dx.doi.org/10.1128/JCM.42.6.2398-2402.2004] [PMID: 15184410]
[2]
Gordon CL, Thompson C, Carapetis JR, Turnidge J, Kilburn C, Currie BJ. Trough concentrations of vancomycin: Adult therapeutic targets are not appropriate for children. Pediatr Infect Dis J 2012; 31(12): 1269-71.
[http://dx.doi.org/10.1097/INF.0b013e31826a3eaf] [PMID: 22828642]
[3]
Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the infectious diseases society of America, and the society of infectious diseases pharmacists. Am J Health Syst Pharm 2009; 66(1): 82-98.
[http://dx.doi.org/10.2146/ajhp080434] [PMID: 19106348]
[4]
Le J, Bradley JS, Murray W, et al. Improved vancomycin dosing in children using area under the curve exposure. Pediatr Infect Dis J 2013; 32(4): e155-63.
[http://dx.doi.org/10.1097/INF.0b013e318286378e] [PMID: 23340565]
[5]
Miloslavsky M, Galler MF, Moawad I, Actis J, Cummings BM, El Saleeby CM. The impact of pediatric-specific vancomycin dosing guidelines: A quality improvement initiative. Pediatrics 2017; 139(6): e20162423.
[http://dx.doi.org/10.1542/peds.2016-2423] [PMID: 28562258]
[6]
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary. Clin Infect Dis 2011; 52(3): 285-92.
[http://dx.doi.org/10.1093/cid/cir034] [PMID: 21217178]
[7]
Dolan E, Hellinga R, London M, Ryan K, Dehority W. Effect of vancomycin loading doses on the attainment of target trough concentrations in hospitalized children. J Pediatr Pharmacol Ther 2020; 25(5): 423-30.
[http://dx.doi.org/10.5863/1551-6776-25.5.423] [PMID: 32641912]
[8]
Hwang D, Chiu NC, Chang L, et al. Vancomycin dosing and target attainment in children. J Microbiol Immunol Infect 2017; 50(4): 494-9.
[http://dx.doi.org/10.1016/j.jmii.2015.08.027] [PMID: 26462708]
[9]
Eiland LS, English TM, Eiland EH III. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients. Ann Pharmacother 2011; 45(5): 582-9.
[http://dx.doi.org/10.1345/aph.1P588] [PMID: 21521865]
[10]
Al-Sulaiti FK, Nader AM, Saad MO, et al. Clinical and pharmacokinetic outcomes of peak-trough-based versus trough-based vancomycin therapeutic drug monitoring approaches: A pragmatic randomized controlled trial. Eur J Drug Metab Pharmacokinet 2019; 44(5): 639-52.
[http://dx.doi.org/10.1007/s13318-019-00551-1] [PMID: 30919233]
[11]
Buck ML. Vancomycin-associated nephrotoxicity and the use of higher trough concentrations in infants and children. Pediatr Pharmacother 2014; 20(10)
[12]
Chia NC, Ming CC, Chih CW. A retrospective study to estimate serum vancomycin trough concentrations in pediatric patients with current recommended dosing regimen. Yixue Yanjiu Zazhi 2018; 38(6): 275-9.
[http://dx.doi.org/10.4103/jmedsci.jmedsci_103_18]
[13]
Frymoyer A, Hersh AL, Coralic Z, Benet LZ, Joseph Guglielmo B. Prediction of vancomycin pharmacodynamics in children with invasive methicillin-resistant Staphylococcus aureus infections: A Monte Carlo simulation. Clin Ther 2010; 32(3): 534-42.
[http://dx.doi.org/10.1016/j.clinthera.2010.03.005] [PMID: 20399990]
[14]
Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Pediatr Infect Dis J 2009; 28(5): 398-402.
[http://dx.doi.org/10.1097/INF.0b013e3181906e40] [PMID: 19295465]
[15]
Rajon K, Vaillancourt R, Varughese N, Villarreal G. Vancomycin use, dosing and serum trough concentrations in the pediatric population: A retrospective institutional review. Pharm Pract (Granada) 2017; 15(2): 887.
[http://dx.doi.org/10.18549/PharmPract.2017.02.887] [PMID: 28690689]
[16]
Qian X, Du G, Weng C, Zhou H, Zhou X. Evaluation of the variability and safety of serum trough concentrations of vancomycin in pa-tients admitted to the intensive care unit. Int J Infect Dis 2017; 60: 17-22.
[http://dx.doi.org/10.1016/j.ijid.2017.04.018] [PMID: 28457752]
[17]
Neely MN, Youn G, Jones B, et al. Are vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother 2014; 58(1): 309-16.
[http://dx.doi.org/10.1128/AAC.01653-13] [PMID: 24165176]
[18]
Tan WH, Brown N, Kelsall AW, McClure RJ. Dose regimen for vancomycin not needing serum peak levels? Arch Dis Child Fetal Neonatal Ed 2002; 87(3): F214-6.
[http://dx.doi.org/10.1136/fn.87.3.F214] [PMID: 12390995]
[19]
Tongsai S, Koomanachai P. The safety and efficacy of high Versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: A meta-analysis. BMC Res Notes 2016; 9(1): 455.
[http://dx.doi.org/10.1186/s13104-016-2252-7] [PMID: 27686168]

Rights & Permissions Print Cite
Article Metrics
25
1
© 2024 Bentham Science Publishers | Privacy Policy